Medical Subject Headings

Last uploaded: July 6, 2018
Preferred Name

7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

Synonyms

BOL-303224-A

ID

http://purl.bioontology.org/ontology/MESH/C522124

altLabel

BOL-303224-A

besivance

7-((3R)-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

besifloxacin

cui

C1959472

C2710017

C2351042

C3886519

HM

D001381

D024841

Inverse of RB

BFE2NBZ7NX

isa

http://purl.bioontology.org/ontology/MESH/D059005

LT

TRD

Mapped to

http://purl.bioontology.org/ontology/MESH/D001381

http://purl.bioontology.org/ontology/MESH/D024841

MDA

20070817

MeSH Frequency

61

MMR

20171016

notation

C522124

PA

D059005

prefLabel

7-(3-aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid

SC

1

Scope Statement

structure in first source

SRC

J Ocul Pharmacol Ther. 2007 Jun;23(3):243-56

TERMUI

T704222

T000867031

T704221

T715281

T000867029

TH

NLM (2008)

FDA SRS (2013)

NLM (2007)

NLM (2014)

INN (19XX)

tui

T109

T195

T121

Delete Subject Author Type Created
No notes to display
Create New Mapping

Delete Mapping To Ontology Source
http://purl.bioontology.org/ontology/LNC/MTHU046360 LOINC CUI
http://purl.bioontology.org/ontology/RXNORM/819911 RXNORM CUI
http://purl.bioontology.org/ontology/SCTSPA/442870007 SCTSPA CUI
http://purl.bioontology.org/ontology/RXNORM/850306 RXNORM CUI
http://purl.bioontology.org/ontology/NDDF/013123 NDDF CUI
http://purl.bioontology.org/ontology/NDFRT/N0000178482 NDFRT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/442870007 SNOMEDCT CUI
http://purl.bioontology.org/ontology/SNOMEDCT/442915008 SNOMEDCT CUI
http://purl.bioontology.org/ontology/LNC/LP172556-5 LOINC CUI
http://purl.bioontology.org/ontology/VANDF/4028790 VANDF CUI
http://purl.bioontology.org/ontology/SCTSPA/442915008 SCTSPA CUI
http://purl.bioontology.org/ontology/UATC/S01AE08 ATC CUI